Home › Funds › Propel Bio Management, LLC › CMPS
Propel Bio Management, LLC position in CMPS
COMPASS PATHWAYS PLC · Health Care
Propel Bio Management, LLC reported holding 549,186 shares of CMPS (COMPASS PATHWAYS PLC) in its Q3 2026 13F filing — a position valued at US$6.8M, representing 3.62% of its reported portfolio and ranking #9 among its reported holdings. Propel Bio Management, LLC has disclosed CMPS holdings in 7 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Propel Bio Management, LLC's CMPS position evolved
Propel Bio Management, LLC first disclosed a stake in CMPS in Q3 2024 at 80,000 shares (US$504K). The position peaked in Q2 2026 at 573,086 shares, worth US$8.1M. Across 7 filings, Propel Bio Management, LLC increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 549,186 shares valued at US$6.8M — a reduction of -23,900 shares quarter over quarter.. Notable position changes include a 68% trim in Q4 2024 (shares fell 24% over the following quarter), a 69% increase in Q4 2025 (shares fell 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 80.00K | $504.00K | New |
| Q4 2024 | 25.21K | $95.29K | Reduce |
| Q3 2025 | 510.00K | $2.92M | New |
| Q4 2025 | 861.78K | $5.95M | Add |
| Q1 2026 | 742.05K | $4.12M | Reduce |
| Q2 2026 | 573.09K | $8.11M | Reduce |
| Q3 2026 | 549.19K | $6.83M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CMPS and 13F data
CMPS (COMPASS PATHWAYS PLC) is a Health Care company. 62 other funds we track also report a position in CMPS — the largest reported positions include Deep Track Capital, LP (US$172.1M), RTW INVESTMENTS, LP (US$151.4M), BIT Capital GmbH (US$111.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CMPS
- Deep Track Capital, LP 12.16M sh · $172.09M · Q2 2026
- RTW INVESTMENTS, LP 10.70M sh · $151.42M · Q2 2026
- BIT Capital GmbH 8.97M sh · $111.56M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 5.00M sh · $70.75M · Q2 2026
- Logos Global Management LP 2.25M sh · $31.84M · Q2 2026
- Eagle Health Investments LP 2.06M sh · $29.16M · Q2 2026
- DAFNA Capital Management LLC 2.01M sh · $28.47M · Q2 2026
- NEXTBio Capital Management LP 1.78M sh · $22.09M · Q3 2026
- Aisling Capital Management LP 1.73M sh · $21.55M · Q3 2026
- Creek Drive Management Group LLC 1.33M sh · $16.52M · Q3 2026
- Patient Square Capital LP 1.06M sh · $13.14M · Q3 2026
- Axxion S.A. 844.35K sh · $10.50M · Q3 2026
More on Propel Bio Management, LLC
FAQ
How long has Propel Bio Management, LLC held CMPS?
Propel Bio Management, LLC has disclosed CMPS holdings in 7 of the last 9 reported quarters, going back to Q3 2024.
What is Propel Bio Management, LLC's current position in CMPS?
As of Q3 2026, Propel Bio Management, LLC holds 549.19K shares of CMPS (COMPASS PATHWAYS PLC), valued at $6.83M, representing 3.62% of its reported portfolio and ranking #9.
Has Propel Bio Management, LLC been buying or selling CMPS?
In the latest 13F filing (Q3 2026), Propel Bio Management, LLC reduced its position in CMPS. The position peaked in Q2 2026 at 573.09K shares.
Which other funds hold CMPS?
Other major institutional holders of CMPS include Deep Track Capital, LP, RTW INVESTMENTS, LP, BIT Capital GmbH, among 62 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.